Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Zieger, Karsten ^a   Wiuf, Carsten ^b   Jensen, Klaus Møller Ernst ^a   Ørntoft, Torben ^a   Dyrskjøt, Lars ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; CASE CONTROL STUDY; CHROMOSOMAL INSTABILITY; CHROMOSOME 8P; CHROMOSOME LOSS; CONTROLLED STUDY; DNA COPY NUMBER CHANGE; FEMALE; FRACTION OF THE GENOME ALTERED; GENE LOCUS; GENETIC HETEROGENEITY; GENETIC PARAMETERS; GENOME ANALYSIS; HETEROZYGOSITY LOSS; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MUSCLE METASTASIS; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; PROGNOSIS; PROGRESSION FREE SURVIVAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR RECURRENCE; BLADDER TUMOR; CHROMOSOME ABERRATION; DISEASE COURSE; GENE DOSAGE; GENETICS; HUMAN GENOME; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHROMOSOME ABERRATIONS; DISEASE PROGRESSION; FEMALE; GENE DOSAGE; GENOME, HUMAN; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; URINARY BLADDER NEOPLASMS;

EID: 67649243719     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-149     Document Type: Article

References (23)

1. Herr HW Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients World J Urol 1997 15 84 88 10.1007/ BF02201977 9144896
2. Zieger K Olsen PR Wolf H Hojgaard K Long term follow-up of superficial invasive bladder carcinoma with or without concomitant epithelial atypia - recurrence and progression Scand J Urol Nephrol 2002, 36:52-59. 10.1080/003655902317259373 12002359
3. Sylvester RJ Meijden van der AP Oosterlinck W Witjes JA Bouffioux C Denis L et al Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials Eur Urol 2006, 49:466-5. 10.1016/j.eururo.2005.12.031 16442208
4. Spruck CH III Ohneseit PF Gonzalez-Zulueta M Esrig D Miyao N Tsai YC et al Two molecular pathways to transitional cell carcinoma of the bladder Cancer Res 1994, 54:784-788. 8306342
5. Hartmann A Schlake G Zaak D Hungerhuber E Hofstetter A Hofstaedter F et al Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder Cancer Res 2002, 62:809-818. 11830537
6. Catto JW Meuth M Hamdy FC Genetic instability and transitional cell carcinoma of the bladder BJU Int 2004, 93:19-24. 10.1111/ j.1464-410X.2004.04548.x 14678361
7. van Rhijn BW Poel van der HG Kwast van der TH Urine markers for bladder cancer surveillance: A systematic review Eur Urol 2005, 47:736-748. 10.1016/j.eururo.2005.03.014 15925067
8. Richter J Wagner U Schraml P Maurer R Alund G Knonagel H et al Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer Cancer Res 1999, 59:5687-5691. 10582685
9. Hoque MO Lee CC Cairns P Schoenberg M Sidransky D Genome-wide genetic characterization of bladder cancer: A comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis Cancer Res 2003, 63:2216-2222. 12727842
10. Koed K Wiuf C Christensen LL Wikman FP Zieger K Moller K et al High-density single nucleotide polymorphism array defines novel stage and location-dependent allelic imbalances in human bladder tumors Cancer Res 2005, 65:34-45. 15665277
11. Blaveri E Brewer JL Roydasgupta R Fridlyand J DeVries S Koppie T et al Bladder cancer stage and outcome by array-based comparative genomic hybridization Clin Cancer Res 2005, 11:7012-7022. 10.1158/ 1078-0432.CCR-05-0177 16203795
12. Veltman JA Fridlyand J Pejavar S Olshen AB Korkola JE DeVries S et al Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors Cancer Res 2003, 63:2872-2880. 12782593
13. Hurst CD Fiegler H Carr P Williams S Carter NP Knowles MA High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization Oncogene 2004, 23:2250-2263. 10.1038/sj.onc.1207260 14968109
14. Zhao X Li C Paez JG Chin K Janne PA Chen TH et al An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays Cancer Res 2004, 64:3060-3071. 10.1158/ 0008-5472.CAN-03-3308 15126342
15. Bergkvist A Ljungqvist A Moberger G Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years Acta Chir Scand 1965, 130:371-378. 5842510
16. Zieger K Dyrskjot L Wiuf C Jensen JL Andersen CL Jensen KM et al Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors Clin Cancer Res 2005, 11:7709-7719. 10.1158/1078-0432.CCR-05-1130 16278391
17. Lin M Wei LJ Sellers WR Lieberfarb M Wong WH Li C dChipSNP: Significance curve and clustering of SNP-array-based loss-of-heterozygosity data Bioinformatics 2004, 20:1233-1240. 10.1093/bioinformatics/bth069 14871870
18. Hafner C Knuechel R Stoehr R Hartmann A Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies Int J Cancer 2002, 101:1-6. 10.1002/ijc.10544 12209580
19. Hoglund M On the origin of syn- and metachronous urothelial carcinomas Eur Urol 2007, 51:1185-1193. 10.1016/j.eururo.2006.11.025 17123702
20. Adams J Williams SV Aveyard JS Knowles MA Loss of heterozygosity analysis and DNA copy number measurement on 8p in bladder cancer reveals two mechanisms of allelic loss Cancer Res 2005, 65:66-75. 15665280
21. Stoehr R Wissmann C Suzuki H Knuechel R Krieg RC Klopocki E et al Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer Lab Invest 2004, 84:465-478. 10.1038/ labinvest.3700068 14968126
22. Dyrskjot L Zieger K Kruhoffer M Thykjaer T Jensen JL Primdahl H et al A molecular signature in superficial bladder carcinoma predicts clinical outcome Clin Cancer Res 2005, 11:4029-4036. 10.1158/ 1078-0432.CCR-04-2095 15930337
23. Busch C Algaba F The WHO/ISUP 1998 and WHO 1999 systems for malignancy grading of bladder cancer. Scientific foundation and translation to one another and previous systems Virchows Arch 2002, 441:105-108. 10.1007/ s00428-002-0633-x 12189498